Cytarabine and Sublimaze drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cytarabine (cytarabine) and Sublimaze (fentanyl citrate). Common drug interactions include febrile neutropenia among females and drug-induced liver injury among males.

The phase IV clinical study analyzes what interactions people have when they take Cytarabine and Sublimaze. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Cytarabine?

Cytarabine has active ingredients of cytarabine. It is often used in acute myelogenous leukemia (aml) - adult. eHealthMe is studying from 65,358 Cytarabine users. Check the latest studies of Cytarabine.

What is Sublimaze?

Sublimaze has active ingredients of fentanyl citrate. eHealthMe is studying from 560 Sublimaze users. Check the latest studies of Sublimaze.



On Jul, 13, 2026

16 people who take Cytarabine and Sublimaze together, and have interactions are studied.

Cytarabine and Sublimaze drug interactions.

What are the common drug interactions of Cytarabine and Sublimaze, by gender? *:

female:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Fungaemia (fungi circulate in the blood)
  3. Neutropenic colitis (inflammation of the cecum, often with involvement of the ascending colon and ileum, a life threatening condition)
  4. Respiratory failure (inadequate gas exchange by the respiratory system)
  5. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
  6. Blood creatinine increased
  7. Cardiac ventricular disorder (ventricular dysfunction of heart)
  8. Conduction disorder (serious disorder of the heart not responses proper to impulses)
  9. Constipation
  10. Culture urine positive

male:

  1. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  2. Sepsis (a severe blood infection that can lead to organ failure and death)
  3. Pneumonia
  4. Pulmonary oedema (fluid accumulation in the lungs)
  5. Respiratory distress (difficulty in breathing)
  6. Blood bilirubin increased
  7. Bone marrow failure
  8. Cardiomegaly (increased size of heart than normal)
  9. Flatulence (flatus expelled through the anus)
  10. Hydronephrosis (water inside the kidney)

What are the common drug interactions of Cytarabine and Sublimaze, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
  2. Blood creatinine increased
  3. Cardiac ventricular disorder (ventricular dysfunction of heart)
  4. Conduction disorder (serious disorder of the heart not responses proper to impulses)
  5. Constipation
  6. Culture urine positive
  7. Diarrhoea
  8. Dyspnoea (difficult or laboured respiration)
  9. Electrocardiogram st-t change
  10. Enterococcal infection

50-59:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Fungaemia (fungi circulate in the blood)
  3. Neutropenic colitis (inflammation of the cecum, often with involvement of the ascending colon and ileum, a life threatening condition)
  4. Respiratory failure (inadequate gas exchange by the respiratory system)
  5. Stomatitis (inflammation of mucous membrane of mouth)

60+:

  1. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  2. Sepsis (a severe blood infection that can lead to organ failure and death)
  3. Pulmonary oedema (fluid accumulation in the lungs)
  4. Respiratory distress (difficulty in breathing)
  5. Blood bilirubin increased
  6. Bone marrow failure
  7. Cardiomegaly (increased size of heart than normal)
  8. Flatulence (flatus expelled through the anus)
  9. Hydronephrosis (water inside the kidney)
  10. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)

What are the existing conditions these people have? *

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 14 people, 87.50%
  2. Pain: 5 people, 31.25%
  3. Infection: 4 people, 25.00%
  4. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 25.00%
  5. Dyspnea (difficult or laboured breathing): 4 people, 25.00%
  6. Fever: 4 people, 25.00%
  7. High Blood Pressure: 4 people, 25.00%
  8. Hypokalemia (low potassium): 4 people, 25.00%
  9. Insomnia (sleeplessness): 4 people, 25.00%
  10. Constipation: 4 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cytarabine and Sublimaze?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cytarabine and Sublimaze:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cytarabine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Sublimaze:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cytarabine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sublimaze and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cytarabine and fentanyl citrate (the active ingredients of Cytarabine and Sublimaze, respectively), and Cytarabine and Sublimaze (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: